Randomized controlled trial comparing highly purified (HP-hCG) and recombinant hCG (r-hCG) for triggering ovulation in ART

References

• Jones HW Jr, Jones GS, Andrews MC, Acosta A, Bundren C, Garcia J, Sandow B, et al. The program for in vitro fertilization at Norfolk. Fertil Steril 1982;38:14–21.
   PubMed Web of Science ®Google Scholar
• Schipper I, Hop WC, Fauser BC. The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development. J Clin Endocrinol Metab 1998;83:1292–1298.
   PubMed Web of Science ®Google Scholar
• Trounson AO, Leeton JF, Wood C, Webb J, Wood J. Pregnancies in humans by fertilization in vitro and embryo transfer in the controlled ovulatory cycle. Science 1981;212:681–682.
   PubMed Web of Science ®Google Scholar
• Rabau E, Serr DM, Mashiach S, Insler V, Salomy M, Lunenfeld B. Current concepts in the treatment of anovulation. Br Med J 1967;4:446–449.
   PubMedGoogle Scholar
• Hsueh AJ, Jones PB. Extrapituitary actions of gonadotropin-releasing hormone. Endocr Rev 1981;2:437–461.
   PubMed Web of Science ®Google Scholar
• Chang P, Kenley S, Burns T, Denton G, Currie K, DeVane G, O’Dea L. Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (Ovidrel) to urinary hCG (Profasi) for induction of final follicular maturation in in vitro fertilization-embryo transfer. Fertil Steril 2001;76:67–74.
   PubMed Web of Science ®Google Scholar
• Al-Inany H, Aboulghar MA, Mansour RT, Proctor M. Recombinant versus urinary gonadotrophins for triggering ovulation in assisted conception. Hum Reprod 2005;20:2061–2073.
   PubMed Web of Science ®Google Scholar
• Institut-Pasteur. Evaluation of viral safety level associated to the purification process for the human chorionic gonadotropin (hCG) produced by IBSA - millipore nanofiltration system. Project nr 287/01 Exp 5362 2003, IBSA Data on file.
   Google Scholar
• Bassett R, De Bellis C, Chiacchiarini L, Mendola D, Micangeli E, Minari K, Grimaldi L, et al. Comparative characterisation of a commercial human chorionic gonadotrophin extracted from human urine with a commercial recombinant human chorionic gonadotrophin. Curr Med Res Opin 2005;21:1969–1976.
   PubMed Web of Science ®Google Scholar
• Yarram SJ, Jenkins J, Cole LA, Brown NL, Sandy JR, Mansell JP. Epidermal growth factor contamination and concentrations of intact human chorionic gonadotropin in commercial preparations. Fertil Steril 2004;82:232–233.
   PubMed Web of Science ®Google Scholar
• Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. J Pharmacol Pharmacother 2010;1:100–107.
   PubMedGoogle Scholar
• Popovic-Todorovic B, Loft A, Lindhard A, Bangsbøll S, Andersson AM, Andersen AN. A prospective study of predictive factors of ovarian response in ‘standard’ IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram. Hum Reprod 2003;18:781–787.
   PubMed Web of Science ®Google Scholar
• Driscoll GL, Tyler JP, Hangan JT, Fisher PR, Birdsall MA, Knight DC. A prospective, randomized, controlled, double-blind, double-dummy comparison of recombinant and urinary HCG for inducing oocyte maturation and follicular luteinization in ovarian stimulation. Hum Reprod 2000;15:1305–1310.
   PubMed Web of Science ®Google Scholar
• ERHCGSG. Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment--recombinant HCG versus urinary HCG. The European Recombinant Human Chorionic Gonadotrophin Study Group. Hum Reprod 2000;15:1446–1451.
   PubMed Web of Science ®Google Scholar
• IRHCGSG. Induction of ovulation in World Health Organization group II anovulatory women undergoing follicular stimulation with recombinant human follicle-stimulating hormone: a comparison of recombinant human chorionic gonadotropin (rhCG) and urinary hCG. International Recombinant Human Chorionic Gonadotropin Study Group. Fertil Steril 2001;75:1111–1118.
   PubMed Web of Science ®Google Scholar
• Wide L, Naessén T, Eriksson K. Effects of 17β-oestradiol and norethisterone acetate on sulfonation and sialylation of gonadotrophins in post-menopausal women. Ups J Med Sci 2010;115:97–106.
   PubMed Web of Science ®Google Scholar
• Wide L, Eriksson K, Sluss PM, Hall JE. The common genetic variant of luteinizing hormone has a longer serum half-life than the wild type in heterozygous women. J Clin Endocrinol Metab 2010;95:383–389.
   PubMed Web of Science ®Google Scholar
• Wide L, Eriksson K, Sluss PM, Hall JE. Serum half-life of pituitary gonadotropins is decreased by sulfonation and increased by sialylation in women. J Clin Endocrinol Metab 2009;94:958–964.
   PubMed Web of Science ®Google Scholar
• Grondahl ML, Borup R, Lee YB, Myrhoj V, Meinertz H, Sorensen S. Differences in gene expression of granulosa cells from women undergoing controlled ovarian hyperstimulation with either recombinant follicle-stimulating hormone or highly purified human menopausal gonadotropin. Fertil Steril 2009;91:1820–1830.
   PubMed Web of Science ®Google Scholar
• Papanikolaou EG, Bourgain C, Fatemi H, Verpoest W, Polyzos NP, De Brabanter A, Kolibianakis E, et al. Endometrial advancement after triggering with recombinant or urinary HCG: a randomized controlled pilot study. Reprod Epub 2010;21:50–55.
   Google Scholar